Stay updated on Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T20:32:45.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T12:52:12.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-02-13T12:59:10.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Minor revision update from v3.4.0 to v3.4.1 with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T16:52:34.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page shows a new revision label 'Revision: v3.3.4' replacing the previous 'Revision: v3.3.3'. This is a minor technical update with no impact on the study information.
    Difference
    0.1%
    Check dated 2026-01-15T03:25:12.000Z thumbnail image
  9. Check
    116 days ago
    Change Detected
    Summary
    A consolidated Locations section listing Arizona, Florida, and Minnesota was added, while the prior Arizona/Florida/Minnesota location subsections were removed; the page revision was updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T12:21:37.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Plus Atezolizumab in NSCLC Clinical Trial page.